• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » $4.1 million launches new imaging center for personalized medicines in Scotland

$4.1 million launches new imaging center for personalized medicines in Scotland

March 5, 2014
CenterWatch Staff

A new imaging center, to be part of the University of Glasgow’s $21 million Clinical Research Facility on the New South Glasgow Hospital site, will contribute to the creation of personalized medicines. Scottish Health Secretary Alex Neil announced the $4.1 million in funding.

The new center will house advanced imaging equipment that looks at large groups of patients and finds ways to predict which treatments will be the most efficient and effective.

Neil said, “Personalized medicine holds huge potential in the development of new treatments for diseases such as cancer. It is one of the most significant advances in 21st century health research as it looks to move away from the one treatment fits all approach to one where a patient’s specific genetic makeup determines the most appropriate treatment. This investment shows the Scottish Government’s support for the important work of the University of Glasgow and NHS Greater Glasgow and Clyde to bring innovation into our NHS. This imaging center will ensure that Glasgow continues to be at the forefront of research—allowing them to use new technology that offers a glimpse of the future of personalized medicine.”

Professor Anna Dominiczak, vice principal and head of College of Medical, Veterinary & Life Sciences, University of Glasgow said, "The development of the field of stratified medicine will be critical to the long-term ability of healthcare systems around the world to meet the growing challenges of an aging population and advanced treatment options.”

“Above all,” she continued, “it will benefit patients. Here in Scotland we are uniquely placed to be pioneers in this field and the new South Glasgow Hospitals Campus provides an unrivalled opportunity to promote collaborative stratified medicine across Scotland, the U.K. and beyond. The awarding of $4.1 million capital funding will enable academic developments, particularly a new clinical research facility for stratified medicine clinical trials and a state-of-the-art research imaging suite, to proceed rapidly to ensure this infrastructure is in place when the new South Glasgow Hospital opens in 2015."

Diseases, such as cancer, present slightly differently in each individual. This equipment allows researchers to study the disease in much more detail, giving more certainty as to which particular drug will stop it in its tracks. Personalized medicine offers the potential to improve the targeting of effective treatments to individuals or populations according to their characteristics.  

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing